Actively Recruiting
Treatment Strategies and Survival Outcome for Non-small Cell Lung Cancer With Oncogenic Mutation
Led by Hunan Province Tumor Hospital · Updated on 2024-10-22
6000
Participants Needed
1
Research Sites
401 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to assess the Treatment Strategies and Survival Outcome for Non-small Cell Lung Cancer With Oncogenic Mutation.
CONDITIONS
Official Title
Treatment Strategies and Survival Outcome for Non-small Cell Lung Cancer With Oncogenic Mutation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Understand the trial requirements and provide signed informed consent
- Age 18 years or older
- Histologically or cytologically confirmed stage IV non-small cell lung cancer
- Oncogenic mutations confirmed by an accredited local laboratory, including EGFR, ALK, ROS1, etc.
- ECOG performance status of 0 or 1
- Predicted survival of 12 weeks or more
- Adequate bone marrow and organ function
- Presence of measurable lesions according to RECIST 1.1
You will not qualify if you...
- Does not meet all inclusion criteria
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Yongchang Zhang
Changsha, Hunan, China, 410013
Actively Recruiting
Research Team
Y
Yongchang Zhang, MD
CONTACT
N
Nong Yang, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
7
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here